Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06656338 · ClinicalTrials.gov registry record · NA
Phase 2 Seattle Dietary Biomarkers Development Center
A NA study of Healthy Adults, sponsored by Marian Neuhouser.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06656338: Recruiting NA study of Healthy Adults, sponsored by Marian Neuhouser.
NCT06656338 is a NA study of Healthy Adults that is actively recruiting participants, run by Marian Neuhouser. The registered enrollment target is 30 participants, below the 86-participant average among 33 other Healthy Adults trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06656338, a NA study of Healthy Adults, is actively recruiting participants, sponsored by Marian Neuhouser.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The Seattle Dietary Biomarker Development Center (S-DBDC) aims to advance the science of measuring dietary intake by identification and validation of dietary biomarkers that improve upon self-reported diet. To accomplish this mission, the Seattle DBDC will carry out controlled feeding studies in healthy human volunteers. Metabolomics assays will be conducted on blood and urine specimens collected during the feeding studies for biomarker identification. Stool samples will be collected and archived.
Conditions Studied
Interventions
- OTHER Higher HEI-2020 diet followed by lower HEI-2020 diet
- OTHER Lower HEI-2020 diet followed by higher HEI-2020 diet
Study Locations (1)
Washington
- Fred Hutchinson Cancer Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-03-18 |
| Est. Completion | 2026-11 |
| Phase | NA |
What NCT06656338 shows while recruiting
NCT06656338 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 86-participant average among 33 other Healthy Adults trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Healthy Adults appearing as the primary indexed condition, and to 2 interventions - of which Higher HEI-2020 diet followed by lower HEI-2020 diet is the first listed.
NCT06656338 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06656338 about?
NCT06656338 is a clinical study titled "Phase 2 Seattle Dietary Biomarkers Development Center". The Seattle Dietary Biomarker Development Center (S-DBDC) aims to advance the science of measuring dietary intake by identification and validation of dietary biomarkers that improve upon self-reported diet. To accomplish this mission, the Seattle DBDC will carry out controlled feeding studies in hea...
What is the current status of trial NCT06656338?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-18. Estimated completion is 2026-11.
What conditions does trial NCT06656338 study?
This clinical trial studies the following conditions: Healthy Adults.
What interventions are being tested in trial NCT06656338?
The interventions under investigation include: Higher HEI-2020 diet followed by lower HEI-2020 diet (OTHER), Lower HEI-2020 diet followed by higher HEI-2020 diet (OTHER).
Who is sponsoring clinical trial NCT06656338?
This trial is sponsored by Marian Neuhouser, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06656338 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adults
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06656338's enrollment target sits among peer trials
30 21st of 33 higher than 11 of 33 other Healthy Adults trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Adults trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
RECRUITING · NA
-
Health Properties of Pecan Nut Consumption
RECRUITING · NA
-
The Brain Processes Underlying Speech Motor Learning and Speech Production
RECRUITING · NA
-
Effect of Acute Nitrate Supplementation on Vascular Function in Hispanic, Black and White Population
RECRUITING · NA
-
Pilot Study of the Entarik System With Advanced Functionality in Health Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI